Search results
Results from the WOW.Com Content Network
MDAI, also known as 5,6-methylenedioxy-2-aminoindane, is an entactogen drug of the 2-aminoindane group which is related to MDMA and produces similar subjective effects. [ 4 ] [ 5 ] [ 6 ] [ 1 ] It acts as a selective serotonin and norepinephrine releasing agent (SNRA). [ 2 ]
2-Aminoindane is not scheduled at the federal level in the United States, [12] but may be considered an analog of amphetamine, in which case purchase, sale, or possession could be prosecuted under the Federal Analog Act.
The legal status of aminoindanes varies by country. For example, 2-AI is a controlled substance in China and Sweden. [5] In the United States, it is not scheduled at the federal level but may be considered an analogue of amphetamine, making its sale or possession potentially prosecutable under the Federal Analogue Act.
The United States Army also experimented with the drug, code named EA-1298, while working to develop a truth drug or incapacitating agent. Harold Blauer died in January 1953 after being intravenously injected, without his knowledge or consent, with 450 mg of the drug as part of Project MKUltra .
Search the web. Legal Main; Terms of Service Summary; Terms of Service; Legal Information Privacy Policy. Privacy Policy Highlights
5-Methyl-MDA is not scheduled at the federal level in the United States, [5] but it is possible that 5-Methyl-MDA could legally be considered an analog of MDA, in which case, sales or possession could potentially be prosecuted under the Federal Analogue Act.
MDAI was initially used as part of the Borax combo and was employed more frequently in the past. [2] However, it was largely replaced by 5-MAPB as availability of MDAI became more limited. [ 2 ]
An assortment of several designer drugs. Designer drugs are structural or functional analogues of controlled substances that are designed to mimic the pharmacological effects of the parent drug while avoiding detection or classification as illegal.